Microchimerism and rejection: A meta-analysis

Clinical Transplantation

Volumn 14, Issue 4 I, 2000, Pages 345-350

  Sahota, Amrik ^a   Gao, Sujuan ^b   Hayes, John ^b   Jindal, Rahul M ^c  

^a Rutgers University   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DATA ANALYSIS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; META ANALYSIS; MICROCHIMERISM; ORGAN DONOR; PRIORITY JOURNAL; PUBLICATION; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL ANALYSIS;

GRAFT REJECTION; HUMANS; TRANSPLANTATION IMMUNOLOGY;

EID: 0033916413     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2000.140411.x     Document Type: Article

References (45)

1. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
2. Cell migration and chimerism - a unifying concept in transplantation - with particular reference to HLA matching and tolerance induction
3. Microchimerism, dendritic cell progenitors and transplantation tolerance
4. Chimerism and donor-specific non reactivity 27 to 29 years after kidney allotransplantation
5. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients
6. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients
7. Simultaneous solid organ, bone marrow, and islet transplantation in type I diabetic patients
8. Microchimerism and rejection in clinical transplantation
9. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation
10. Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts
11. Assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry (PCR-Flow)
12. Graft function and rejection patterns in heart-transplanted patients with and without systemic microchimerism
13. Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation
14. Long-term chimerism in liver transplantation: No evidence for immunological relevance but requirement for graft persistence
15. Peripheral blood chimerism following human liver transplantation
16. Detection of blood chimerism after lung transplantation: Superiority of nested as compared to standard polymerase chain amplification
17. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow
18. Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients
19. Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function
20. Systemic chimerism in sex-mismatched liver transplant recipients detected by fluorescence in situ hybridization
21. Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients
22. Enhancement of donor cell chimerism in whole organ allograft recipients by adjuvant bone marrow transplantation
23. Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells
24. Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients
25. Circulating donor antigen and response to donor antigen as predictors of long-term lung and kidney transplant success
26. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients
27. Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients
28. Transmission of donor lymphocytes in clinical lung transplantation
29. High-dose donor bone marrow infusions to enhance allograft survival: The effect of timing
30. Donor-specific bone marrow infusion after orthotopic liver transplantation
31. Donor-type microchimerism associated with graft rejection eight years after liver transplantation
32. Passenger lymphocytes in human liver allografts and their potential role after transplantation
33. Persistence of donor lymphocytes in liver allograft recipients
34. Patterns of donor-type microchimerism after heart transplantation
35. Combined simultaneous kidney/bone marrow transplantation
36. Combined kidney/bone marrow transplantation - Augmentation of chimerism
37. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation
38. Systemic chimerism in human female recipients of male livers
39. Chimerism after transplantation for type IV glycogen storage disease and type I Gaucher's disease
40. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients
41. Serial evaluation of immune profiles of simultaneous bone marrow and whole organ transplant recipients
42. Immune status of recipients following bone marrow-augmented solid organ transplantation
43. Generalized linear models: A pseudo-likelihood approach
44. Meta-analysis of randomized controlled trials: A concern for standards
45. Summing up evidence: One answer is not enough